Background Immunological characteristics of COVID-19 show pathological hyperinflammation associated with lymphopenia and dysfunctional T cell responses. These features provide a rationale for restoring functional T cell immunity in COVID-19 patients by adoptive transfer of SARS-CoV-2 specific T cells. Methods To generate SARS-CoV-2 specific T cells, we isolated peripheral blood mononuclear cells from 7 COVID-19 recovered and 13 unexposed donors. Consequently, we stimulated cells with SARS-CoV-2 peptide mixtures covering spike, membrane and nucleocapsid proteins. Then, we culture expanded cells with IL-2 for 21 days. We assessed immunophenotypes, cytokine profiles, antigen specificity of the final cell products. Results Our results show that SARS-CoV-2 specific T cells could be expanded in both COVID-19 recovered and unexposed groups. Immunophenotypes were similar in both groups showing CD4+ T cell dominance, but CD8+ and CD3+CD56+ T cells were also present. Antigen specificity was determined by ELISPOT, intracellular cytokine assay, and cytotoxicity assays. One out of 14 individuals who were previously unexposed to SARS-CoV-2 failed to show antigen specificity. Moreover, ex-vivo expanded SARS-CoV-2 specific T cells mainly consisted of central and effector memory subsets with reduced alloreactivity against HLA-unmatched cells suggesting the possibility for the development of third-party partial HLA-matching products. Discussion In conclusion, our findings show that SARS-CoV-2 specific T cell can be readily expanded from both COVID-19 and unexposed individuals and can therefore be manufactured as a biopharmaceutical product to treat severe COVID-19 patients. One Sentence Summary Ex-vivo expanded SARS-CoV-2 antigen specific T cells developed as third-party partial HLA-matching products may be a promising approach for treating severe COVID-19 patients that do not respond to previous treatment options.
【저자키워드】 COVID19, T cell therapy, HLA sharing, virus specific T cells, viral immunity, 【초록키워드】 COVID-19, Treatment, SARS-CoV-2, Immunity, T cells, peptide, cytotoxicity, cytokine, Antigen, Peripheral blood, lymphopenia, specificity, T cell, Characteristics, Culture, immunophenotype, hyperinflammation, T cell responses, Peripheral blood mononuclear cells, membrane, ELISPOT, donors, SARS-CoV-2 antigen, CD4+ T cell, COVID-19 patients, IL-2, COVID-19 patient, mononuclear cells, determined by, mononuclear cell, adoptive transfer, both groups, individual, rationale, severe COVID-19 patients, profiles, Nucleocapsid proteins, transfer, Final, treat, CD56, CD8+, effector memory, approach, feature, Cell, stimulated, Result, assays, generate, reduced, functional, was determined, groups, subset, respond, in both group, intracellular cytokine, severe COVID-19 patient, 【제목키워드】 COVID-19, SARS-CoV-2, HLA, Specific, matching, Partial, New,